Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03616379 · ClinicalTrials.gov registry record · NA
Stress Response in Opioid Use Disorder
A NA study, sponsored by Mclean Hospital.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT03616379 is a NA study that has completed, run by Mclean Hospital. The registered enrollment target is 119 participants.
The verdict
NCT03616379, a NA study, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
Opioid use disorder is a major public health problem. Although there are effective treatments for this disorder, many people still relapse and thus there is a need for new treatments to improve outcomes. People who have a strong emotional and physical response to stress are at a higher risk of relapse. The goal of this project is to test the effect of strategies to reduce response to stress in people diagnosed with opioid use disorder. Men and women diagnosed with opioid use disorder will be recruited for a one-session study. Participants will be randomly assigned to one of three brief instructional conditions followed by a brief laboratory stress test. Investigators hypothesize that, compared to education about stress, brief strategies to help people cope with negative emotions will reduce responses to stress and increase tolerance of stress. If this hypothesis is supported, it will inform the development of new treatments to improve outcome in opioid use disorder.
Interventions
- BEHAVIORAL Psychoeducational Control
- BEHAVIORAL Affect Regulation
- BEHAVIORAL Affect Labelling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2019-05-31 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03616379
The ClinicalTrials.gov registry entry for NCT03616379 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Psychoeducational Control is the first listed.
NCT03616379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03616379 about?
NCT03616379 is a clinical study titled "Stress Response in Opioid Use Disorder". Opioid use disorder is a major public health problem. Although there are effective treatments for this disorder, many people still relapse and thus there is a need for new treatments to improve outcomes. People who have a strong emotional and physical response to stress are at a higher risk of relap...
What is the current status of trial NCT03616379?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2019-05-31. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT03616379?
The interventions under investigation include: Psychoeducational Control (BEHAVIORAL), Affect Regulation (BEHAVIORAL), Affect Labelling (BEHAVIORAL).
Who is sponsoring clinical trial NCT03616379?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.